Top compounds associated with response to RWDD4


Feature Type Standardized
Nominal ANOVA
mRNA BRD-A71883111 CTRPv2 pan-cancer AAC -0.072 0.05
mRNA BRD-K96431673 CTRPv2 pan-cancer AAC -0.14 0.05
mRNA etomoxir CTRPv2 pan-cancer AAC -0.074 0.05
mRNA nintedanib CTRPv2 pan-cancer AAC 0.072 0.05
mRNA Ki8751 CTRPv2 pan-cancer AAC 0.069 0.05
mRNA Erlotinib CTRPv2 pan-cancer AAC -0.067 0.05
mRNA tanespimycin:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.061 0.06
mRNA WZ4002 CTRPv2 pan-cancer AAC -0.084 0.06
mRNA MI-2 CTRPv2 pan-cancer AAC -0.1 0.06
mRNA selumetinib:tretinoin (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.066 0.06
Download CSV